Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Double-blind	STARTED	Fosmetpantotenate	41
Double-blind	STARTED	Placebo	43
Double-blind	Received at Least 1 Dose of Study Drug	Fosmetpantotenate	41
Double-blind	Received at Least 1 Dose of Study Drug	Placebo	43
Double-blind	COMPLETED	Fosmetpantotenate	41
Double-blind	COMPLETED	Placebo	37
Double-blind	NOT COMPLETED	Fosmetpantotenate	0
Double-blind	NOT COMPLETED	Placebo	6
Open-label	STARTED	Fosmetpantotenate	41
Open-label	STARTED	Placebo	37
Open-label	Received At Least 1 Dose of Study Drug	Fosmetpantotenate	41
Open-label	Received At Least 1 Dose of Study Drug	Placebo	37
Open-label	COMPLETED	Fosmetpantotenate	0
Open-label	COMPLETED	Placebo	0
Open-label	NOT COMPLETED	Fosmetpantotenate	41
Open-label	NOT COMPLETED	Placebo	37

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03041116/flow